1. Home
  2. CLRB vs LIQT Comparison

CLRB vs LIQT Comparison

Compare CLRB & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • LIQT
  • Stock Information
  • Founded
  • CLRB 2002
  • LIQT 2004
  • Country
  • CLRB United States
  • LIQT Denmark
  • Employees
  • CLRB N/A
  • LIQT N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • LIQT Industrial Machinery/Components
  • Sector
  • CLRB Health Care
  • LIQT Technology
  • Exchange
  • CLRB Nasdaq
  • LIQT Nasdaq
  • Market Cap
  • CLRB 17.6M
  • LIQT 16.1M
  • IPO Year
  • CLRB N/A
  • LIQT N/A
  • Fundamental
  • Price
  • CLRB $4.98
  • LIQT $1.55
  • Analyst Decision
  • CLRB Hold
  • LIQT Strong Buy
  • Analyst Count
  • CLRB 2
  • LIQT 2
  • Target Price
  • CLRB N/A
  • LIQT $4.80
  • AVG Volume (30 Days)
  • CLRB 1.3M
  • LIQT 32.4K
  • Earning Date
  • CLRB 08-12-2025
  • LIQT 08-13-2025
  • Dividend Yield
  • CLRB N/A
  • LIQT N/A
  • EPS Growth
  • CLRB N/A
  • LIQT N/A
  • EPS
  • CLRB N/A
  • LIQT N/A
  • Revenue
  • CLRB N/A
  • LIQT $14,986,815.00
  • Revenue This Year
  • CLRB N/A
  • LIQT $36.89
  • Revenue Next Year
  • CLRB N/A
  • LIQT $16.33
  • P/E Ratio
  • CLRB N/A
  • LIQT N/A
  • Revenue Growth
  • CLRB N/A
  • LIQT N/A
  • 52 Week Low
  • CLRB $4.36
  • LIQT $1.34
  • 52 Week High
  • CLRB $94.50
  • LIQT $3.20
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 33.34
  • LIQT 52.73
  • Support Level
  • CLRB $6.50
  • LIQT $1.55
  • Resistance Level
  • CLRB $8.30
  • LIQT $1.86
  • Average True Range (ATR)
  • CLRB 1.42
  • LIQT 0.10
  • MACD
  • CLRB -0.66
  • LIQT 0.01
  • Stochastic Oscillator
  • CLRB 1.63
  • LIQT 36.59

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.

Share on Social Networks: